EMMA HARRINGTON: Open Payments
NPI 1316200348 · CHEEKTOWAGA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,026 in 50 payments from 18 companies in 2025. Trend: 2023 $505 · 2024 $622 · 2025 $1,026
Food & beverage: $1,026
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 8 | $152 |
| AstraZeneca Pharmaceuticals LP | 2 | $152 |
| Lilly USA, LLC | 8 | $123 |
| Novo Nordisk Inc | 5 | $97 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $94 |
| Otsuka America Pharmaceutical, Inc. | 4 | $89 |
| PFIZER INC. | 3 | $46 |
| GlaxoSmithKline, LLC. | 3 | $45 |
| Exact Sciences Corporation | 2 | $38 |
| Merck Sharp & Dohme LLC | 2 | $34 |
Products named: TZIELD, AIRSUPRA, MOUNJARO, Kerendia, REXULTI, Rybelsus, Cologuard Collection Kit, Ozempic.
Industry payments across NY — which companies pay providers there.
